ViroPharma up on analyst report

VPHM rose $1.72 (11%) to $18.10 on 6.8 million shares on Thursday after Piper Jaffray analyst Thomas Wei raised his VPHM price target to $24 from $18, citing the potential for higher-than-expected pri...